InvestorsHub Logo

emit

01/12/21 4:00 PM

#6667 RE: stervc #6665

xyz is smacking at a truism - SEC is hot on tail of covid plays touting things with no merit; do you think filings will appear?


e

KULiquidGold

01/12/21 9:38 PM

#6686 RE: stervc #6665

Thomas Ross, impressive connections and accomplishments. Very active guy in multiple orgs and companies. Well connected in other countries.

Huge MJTV 8-K Confirms as Supplier...

This is a huge 8-K filed with the SEC by MJTV as it confirms them to be a Supplier and not a Distributor which means more Revenues and Profits to be going into the company from their COVID-19 IgG/IgM Rapid Test Kit sales:
http://archive.fast-edgar.com/20210112/A72GK22CZ222H2M2222G22Y2L9AIZB227232/

It confirms that MJTV should be worth more than what was indicated within this post below:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160597902

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160874409

v/r
Sterling



From LinkedIn
About
Thomas Ross has an international business background, having lived 18 years in Europe, Africa and the Middle East as an independent investment specialist and real estate project developer. He currently heads the Palm Beach Business Group, Inc. a business development and networking organization headquartered in Palm Beach, Florida that helps provide venture funding to early stage biotechnology, life science, alternative energy and other technology companies.

As President of Florida BioSciences, LLC, he supports a growing South Florida as center for international finance and bioscience, Tom helps scientists with "spinout" biotechnology companies from the world famous biomedical research institutes (Scripps, Max Planck, Burnham, etc.) raise funding to get these and other science technology firms to commercialization for the efficient and cost effective treatment of diseases. Technologies include unique immunotherapies and exciting electromagnetic treatments. Accomplishing these goals will reward our clients, as we "do Good" and therefore "do Well".

As Pres, CFO of Invest Africa Global, LLC. Tom has assisted in arranging for major infrastructure projects in W Africa, as well as in the trade of high yield commodities. Africa offers huge emerging market opportunities that IAG will help develop on behalf of US and especially Florida companies, while giving back to needed African charitable organizations.

Chapter President
Keiretsu Forum, Palm Beach Chapter
Dates Employed Jan 2020 – Present

Consulting on non-market correlated investments such as angel and venture stage private equity, largely in the bio-medical space.
Purdue U. BSc Aeronautical Engineering, MSc Industrial Management

President, CFO
Invest Africa Global
Dates Employed Jan 2018 – Present

Invest Africa Global, LLC, via affiliates in Botswana, Nigeria, Republic of Congo, DRC and Namibia, is consulting regarding the development of major infrastructure projects in energy, and petroleum transport and storage. IAG affiliates also trade in high yield commodities as a government authorized trading associate. Mission of IAG - drive business opportunities to American companies while assisting local employment and development.

President, CEO
Florida BioSciences, LLC
Dates Employed 2007 – Present

Florida BioSciences LLC is the management company for innovative venture funds under private placement development that specialize in early stage biomedical technologies. The Anti-Aging Fund emphasizes intra-disciplinary technologies and a CAM approach to medicine, as well as biologics. The Sovereign Emerging Biomedical Fund, LLC, is designed as an early stage bioscience fund which will fund selected portfolio companies for three to four years against agreed milestones. Assisting biomedical companies in their capital requirements outside the funds is also undertaken. http://www.sovereignbiomedical.com/

President
Biomune, Inc.
Dates Employed Jan 2005 – Present

Biomune has a patented technology for stimulating the innate immune system to attack cancer cells using very low cost plant mitogens. Preclinical tests showed 59 of 60 mice cured of three different cancers, an outstanding result. Now raising money for additional preclinical research and nutraceutical applications.

http://www.biomune.us/ws/pages/howitworks.php
http://www.biomune.us/ws/pages/data.php
http://www.biomune.us/ws/pages/about.php